Learners to LeAders in benign Urology, benign Nephrology, and non-Cancer Hematology

项目摘要 计划概述 这是一个统一的U2 C/TL 1培训计划（良性泌尿外科的学习者到领导者， 肾脏病学和非癌症血液学[LAUNCH]计划），旨在整合，扩展和改造 在北方加州的肾脏、泌尿和血液（KUH）生物医学研究培训。基于四个 拥有优秀科研资源和人才培养能力的院校--加州San 弗朗西斯科（UCSF）、加州伯克利大学（UC Berkeley）、加州戴维斯大学（UC Davis）、 和斯坦福大学-我们提出了一种创新的方法来培养22名（4名博士前和18名博士后）学员 每年在成人和儿科KUH学科。我们将确定和招募最有前途的和多样化的 一组学员，使他们能够进行KUH研究，并为这些发射计划学员提供 优秀的基础，转化或临床研究培训。我们的总体目标是建立统一的培训 促进跨学科合作和培训最有前途的初级研究人员的计划 我们的四个机构。因此，我们预计，发射计划将毕业的科学家谁是好- 训练有素，能够成功地竞争研究资金，并能够创造性地思考和协作， 产生新颖和有影响力的科学。启动计划将由U2 C多PI领导（Elaine博士 Ku，马歇尔斯托勒和凯瑟琳坂本）以及TL 1多PI（许致远博士，菲利普比奇， 和马克沃尔特斯），他们每个人都拥有互补的专业知识，在研究和研究培训， 肾脏学、泌尿学和血液学学科。我们拥有世界一流的培训师资， 入选我们项目的不仅是他们自己的科学和学术成就， 以及他们的指导记录和对培训的承诺。发射计划是仿照 我们的机构中有几个非常成功的培训项目， 来自不同学科的科学家使用团队科学方法。

PROJECT ABSTRACT Program Overview This is a single consolidated U2C/TL1 training program (the Learners to LeAders in benign Urology, benign Nephrology, and non-Cancer Hematology [LAUNCH] Program) that seeks to integrate, expand, and transform kidney, urologic, and hematologic (KUH) biomedical research training in Northern California. Based at four institutions with outstanding research resources and training accomplishments—University of California San Francisco (UCSF), University of California Berkeley (UC Berkeley), University of California Davis (UC Davis), and Stanford University—we propose an innovative approach to train 22 (4 pre- and 18 post-doctoral) trainees annually across adult and pediatric KUH disciplines. We will identify and recruit the most promising and diverse group of trainees to enable them to conduct KUH research and provide these LAUNCH Program trainees with outstanding basic, translational, or clinical research training. Our overall goal is to establish a unified training program that promotes interdisciplinary collaboration and training of the most promising junior investigators across our four institutions. Thus, we expect that the LAUNCH Program will graduate scientists who are well- trained, able to compete successfully for research funding, and able to think creatively and collaboratively to generate novel and impactful science. The LAUNCH Program will be led by the U2C multi-PI’s (Drs. Elaine Ku, Marshall Stoller, and Kathleen Sakamoto) as well as the TL1 multi-PI’s (Drs. Chi-yuan Hsu, Philip Beachy, and Mark Walters), each of whom possess complementary expertise in research and research training within the disciplines of nephrology, urology, and hematology. The world-class training faculty whom we have included in our program were selected not only based on their own scientific and scholarly achievements but also their track record of mentorship and commitment to training. The LAUNCH Program is modeled after several highly-successful training programs at our institutions that have trained numerous exceptional scientists from a wide range of disciplines using a team science approach.